Cytek Biosciences Inc. (CTKB)
NASDAQ: CTKB
· Real-Time Price · USD
4.03
-0.05 (-1.23%)
At close: Aug 15, 2025, 3:59 PM
4.00
-0.62%
After-hours: Aug 15, 2025, 05:59 PM EDT
Cytek Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 196.03M | 197.05M | 200.45M | 201.21M | 197.71M | 200.79M | 193.01M | 183.12M | 175.59M | 166.06M | 164.04M | 154.59M | 148.49M | 138.74M | 127.95M | 119.67M | 110.39M | 99.12M |
Cost of Revenue | 89.35M | 88.8M | 89.35M | 90.71M | 89.03M | 89.39M | 83.59M | 77.36M | 70.16M | 64.22M | 63.06M | 59.36M | 58.73M | 53.8M | 48.7M | 44.61M | 41.1M | 41.3M |
Gross Profit | 106.68M | 108.25M | 111.11M | 110.5M | 108.67M | 111.4M | 109.43M | 105.75M | 105.44M | 101.83M | 100.97M | 95.24M | 89.76M | 84.94M | 79.25M | 75.07M | 69.3M | 57.82M |
Operating Income | -26.86M | -24.76M | -20.52M | -23.65M | -25.82M | -26.42M | -27.85M | -27.63M | -18.71M | -10.47M | -665K | 578K | 1.15M | 5.85M | 9.34M | 15.89M | 19.53M | 15.5M |
Interest Income | 3.41M | 4.27M | 5.12M | 5.66M | 5.84M | 5.63M | 6.41M | 7.59M | 7.55M | 6.74M | 4.62M | 2.01M | 439K | 57K | 49K | 36K | 27K | 34K |
Pretax Income | -7.56M | -7.97M | -5.7M | -11.91M | -16.25M | -15.66M | -15.71M | -15.71M | -9.67M | -4.48M | 1.26M | -2.4M | -2M | 2.67M | 6.12M | 13.67M | 18.32M | 15.24M |
Net Income | -6.4M | -11.25M | -6.02M | -10.16M | -17.56M | -11.51M | -12.15M | -14.12M | -6M | -2.21M | 2.44M | -865K | -936K | 2.33M | 4.59M | 9.97M | 14.91M | 20.35M |
Selling & General & Admin | 95.39M | 93.68M | 92.23M | 93.6M | 92.66M | 93.85M | 93.12M | 90.35M | 84.77M | 76.64M | 67.92M | 63.61M | 58.99M | 51.72M | 45.47M | 37.42M | 30.72M | 26.55M |
Research & Development | 38.16M | 39.33M | 39.4M | 40.55M | 41.84M | 43.97M | 44.15M | 43.03M | 40.51M | 36.81M | 34.86M | 32.19M | 29.61M | 27.37M | 24.44M | 21.75M | 19.05M | 15.77M |
Other Expenses | n/a | 59K | 59K | 59K | 59K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -120K | -120K | -120K | -120K | n/a |
Operating Expenses | 133.54M | 133.01M | 131.63M | 134.15M | 134.49M | 137.82M | 137.27M | 133.38M | 125.28M | 113.44M | 102.78M | 95.8M | 88.61M | 79.09M | 69.91M | 59.17M | 49.77M | 42.32M |
Interest Expense | -4K | 544K | 694K | 1.09M | 1.56M | 1.84M | 2.07M | 2.36M | 2.42M | 2.66M | 2.57M | 2.38M | 2.17M | 1.96M | 1.74M | 1.58M | 1.14M | 708K |
Selling & Marketing Expenses | 48.95M | 49.08M | 49.11M | 48.8M | 48.45M | 50.55M | 49.15M | 46.62M | 43.35M | 37.41M | 33.23M | 32.51M | 30.03M | 27.17M | 24.49M | 20.74M | 18.25M | 15.73M |
Cost & Expenses | 222.9M | 221.81M | 220.98M | 224.86M | 223.53M | 227.2M | 220.86M | 210.74M | 195.44M | 177.67M | 165.84M | 155.16M | 147.34M | 132.89M | 118.61M | 103.78M | 90.86M | 83.62M |
Income Tax Expense | -1.16M | 3.28M | 320K | -1.75M | 1.3M | -4.15M | -3.56M | -1.77M | -3.82M | -2.31M | -1.22M | -1.42M | -986K | 310K | 1.5M | 3.71M | 3.41M | -5.11M |
Shares Outstanding (Basic) | 126.93M | 128.34M | 129.21M | 131M | 131.44M | 130.92M | 130.71M | 136.17M | 135.92M | 135.49M | 135M | 134.71M | 134.4M | 133.9M | 108.32M | 108.32M | 130.81M | 124.82M |
Shares Outstanding (Diluted) | 126.93M | 128.34M | 129.21M | 132.79M | 131.44M | 130.92M | 130.71M | 136.17M | 135.92M | 135.49M | 137.03M | 138.71M | 134.4M | 133.9M | 113.64M | 113.64M | 130.81M | 126.92M |
EPS (Basic) | -0.05 | -0.09 | -0.05 | -0.08 | -0.13 | -0.08 | -0.09 | -0.1 | -0.04 | -0.02 | 0.02 | -0.01 | -0.00 | 0.02 | 0.04 | 0.08 | 0.12 | 0.16 |
EPS (Diluted) | -0.05 | -0.09 | -0.05 | -0.08 | -0.13 | -0.08 | -0.09 | -0.1 | -0.04 | -0.02 | 0.02 | -0.01 | -0.00 | 0.02 | 0.04 | 0.08 | 0.12 | 0.16 |
EBITDA | -8.51M | -2.46M | -463K | -5.29M | -9.41M | -9.4M | -10.68M | -6.3M | -1.44M | 3.24M | 8.69M | 4.25M | 3.13M | 6.92M | 9.54M | 15.34M | 19.71M | 16.16M |
EBIT | -26.52M | -22.95M | -20.52M | -10.82M | -14.69M | -13.82M | -13.64M | -13.34M | -8.39M | -2.96M | 2.69M | -560K | 596K | 5.16M | 9.01M | 15.79M | 19.99M | 16.37M |
Depreciation & Amortization | 8.43M | 10.91M | 10.49M | 10.17M | 9.92M | 9.06M | 7.61M | 7.04M | 5.82M | 5.06M | 4.86M | 3.68M | 2.54M | 1.87M | 1.25M | 719K | 704K | 665K |